Literature DB >> 4595266

Clinical evaluation of cephradine, a new oral cephalosporin.

J F Scholand, G R Hodges, R J Fass, S Saslaw.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4595266     DOI: 10.1097/00000441-197402000-00005

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  5 in total

1.  Susceptibility of clinical isolates of Enterobacteriaceae to BL-S640, a new oral cephalosporin.

Authors:  C Watanakunakorn; T Bannister; C Glotzbecker
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

2.  In vitro susceptibility studies with cefaclor and cephalexin.

Authors:  W M Scheld; O M Korzeniowski; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

3.  Comparison of in vitro activity of cephalexin, cephradine, and cefaclor.

Authors:  N J Bill; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

4.  In vitro and clinical studies of cefatrizine, a new semisynthetic cephalosporin.

Authors:  R del Busto; E Haas; T Madhaven; K Burch; F Cox; E Fisher; E Quinn; D Pohlod
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

Review 5.  The cephalosporins: activity and clinical use.

Authors:  A J Weinstein
Journal:  Drugs       Date:  1980-08       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.